Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 257 Neoplasms 225 Carcinoma, Non-Small-Cell Lung 206 Colorectal Neoplasms 148 Prostatic Neoplasms 142 Lung Neoplasms 116 Neoplasm Metastasis 106 Ovarian Neoplasms 103 Multiple Myeloma 98 Pancreatic Neoplasms 89 Leukemia, Myeloid, Acute 79 Squamous Cell Carcinoma of Head and Neck 75 Endometrial Neoplasms 65 Melanoma 64 Stomach Neoplasms 60 Recurrence 59 Glioblastoma 57 Brain Neoplasms 56 Urinary Bladder Neoplasms 51 Carcinoma, Hepatocellular 51 Triple Negative Breast Neoplasms 50 Precursor Cell Lymphoblastic Leukemia-Lymphoma 49 Lymphoma 48 Head and Neck Neoplasms 47 Carcinoma, Renal Cell 46 Hematologic Neoplasms 44 Esophageal Neoplasms 43 Colonic Neoplasms 43 Uterine Cervical Neoplasms 42 Glioma 42

Interventions

ribociclib 1 Letrozole 1 Goserelin 1 Chemotherapy, Adjuvant 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × HER2 Negative Breast Cancer × 30 days × Clear all

NCT06953882 2026-05-26

SELECT

Yale University

Phase 2 Recruiting

HER2 Negative Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡